Back to Search
TRACY BATCHELOR, MD MPH
MD MPH
Neurology Physician
NPI: 1952391260IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
81733(MA)
CMS Specialties
PrimaryNEUROLOGY
Education
EMORY UNIVERSITY SCHOOL OF MEDICINE
Class of 1990
Research & Publications (20)
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.
PMID 17222792·Cancer Cell·2007
3-trial
Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: final report of NABTT 97-11.
PMID 14769136·Neuro Oncol·2004
3-trial
Age-dependent prognostic effects of genetic alterations in glioblastoma.
PMID 14734474·Clin Cancer Res·2004
8-other
Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07.
PMID 12637469·J Clin Oncol·2003
3-trial
High-dose methotrexate for isolated central nervous system relapse in patients with testicular non-Hodgkin's lymphoma.
PMID 11707852·Clin Lymphoma·2001
5-case
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 1-2005. A 35-year-old woman with difficulty walking, headache, and nausea.
PMID 15647582·N Engl J Med·2005
5-case
A persistent sciatic artery aneurysm with an associated internal iliac artery aneurysm.
PMID 11035976·Eur J Vasc Endovasc Surg·2000
5-case
Decreased rate of infection in glioblastoma patients with allelic loss of chromosome 10q.
PMID 19430887·J Neurooncol·2009
8-other
Biomarkers of response and resistance to antiangiogenic therapy.
PMID 19483739·Nat Rev Clin Oncol·2009
6-review
A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients.
PMID 19549889·Cancer Res·2009
8-other
Prospective study of meat intake and dietary nitrates, nitrites, and nitrosamines and risk of adult glioma.
PMID 19587083·Am J Clin Nutr·2009
8-other
Cediranib: profile of a novel anti-angiogenic agent in patients with glioblastoma.
PMID 19671039·Expert Opin Investig Drugs·2009
6-review
Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial.
PMID 19636006·J Clin Oncol·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 60 FENWOOD RD # YAW9
BOSTON, MA 02115 - Phone
- (617) 732-5500
Quick Facts
- NPI
- 1952391260
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile